4 Healthcare Stocks Raising Dividends Through Two Recessions

Four blue-chip healthcare stocks have consistently raised their dividends through two recessions in just over two decades. The companies are Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Medtronic (MDT), and Becton, Dickinson (BDX). These shares have withstood the 2008 financial crisis and the 2020 COVID-19 shock, thanks to their inelastic demand for drugs, diagnostics, and medical devices.

J&J has a 64-year dividend raise streak backed by $21 billion in free cash flow. The company's trailing EPS comfortably covers its trailing dividend of $5.24. J&J has also posted year-to-date FCF of about $8.7 billion, guided full-year free cash flow approaching $21 billion, and ended Q2 with roughly $21 billion in cash and marketable securities.

Abbott Laboratories is a Dividend Aristocrat with 54 consecutive years of raises and paid its 410th consecutive quarterly dividend in August. The company's trailing EPS of $3.12 covers the $2.48 trailing dividend, and Q2 shareholder returns totaled $2.1 billion via dividends and buybacks.

Medtronic is the yield leader at 3.16%, with shares at $90.83. The board bumped the quarterly payout from $0.71 to $0.72 in June, taking the annualized forward to $2.88. Medtronic ended Q4 with 9.2 billion in cash and investments, and fiscal 2026 free cash flow was $5.4 billion.

Becton, Dickinson has a track record of continuous quarterly payments and steady annual increases from $0.37 in 2010 to $1.05 in 2026. The company's year-to-date FCF was $1.7 billion, an increase of 45% versus the prior year.

The four healthcare stocks offer durability over headline yield due to their cash generation running on inelastic demand. For a defensive income sleeve built to survive the next downturn, this is the healthcare shortlist.